Diseases, Conditions, Syndromes

FDA approves Rinvoq for treatment of atopic dermatitis

The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older, the manufacturer announced Friday.

Diseases, Conditions, Syndromes

Can inhaled corticosteroids alleviate early symptoms of COVID-19?

Despite high hopes, a new pan-Canadian study published today in The BMJ suggests that ciclesonide—an inhaled and nasal steroid drug commonly used for asthma and rhinitis—won't be the treatment to change the course of ...

Medications

Tailoring treatment of patients with COPD

Patients with COPD are treated with drugs to improve the breathing ability in combination with inhaled corticosteroids to reduce the risk of acute worsening of the lung conditions. But the balance between reduced exacerbations ...

Diseases, Conditions, Syndromes

Monthly COVID-19 hospitalization rates peaked in December 2020

(HealthDay)—For adults hospitalized with COVID-19, monthly rates of hospitalization, intensive care unit (ICU) admission, and death peaked in December 2020, according to a study published online Aug. 10 in the Annals of ...

page 4 from 24